Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nTreg therapy for kidney transplant rejection
NCT02129881Phase 2Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Apr 2014
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
A Phase 2 trial of autologous regulatory T cell product in kidney transplant rejection, sponsored by Guy's and St Thomas' NHS Foundation Trust. Started Apr 2014; status: completed.
02
Drugs
autologous regulatory T cell product
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02129881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02129881.